GB202311340D0 - Cancer diagnosis and treatment - Google Patents

Cancer diagnosis and treatment

Info

Publication number
GB202311340D0
GB202311340D0 GBGB2311340.0A GB202311340A GB202311340D0 GB 202311340 D0 GB202311340 D0 GB 202311340D0 GB 202311340 A GB202311340 A GB 202311340A GB 202311340 D0 GB202311340 D0 GB 202311340D0
Authority
GB
United Kingdom
Prior art keywords
treatment
cancer diagnosis
diagnosis
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2311340.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vestlandets Innovasjonsselskap AS
Original Assignee
Vestlandets Innovasjonsselskap AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestlandets Innovasjonsselskap AS filed Critical Vestlandets Innovasjonsselskap AS
Priority to GBGB2311340.0A priority Critical patent/GB202311340D0/en
Publication of GB202311340D0 publication Critical patent/GB202311340D0/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
GBGB2311340.0A 2023-07-24 2023-07-24 Cancer diagnosis and treatment Pending GB202311340D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2311340.0A GB202311340D0 (en) 2023-07-24 2023-07-24 Cancer diagnosis and treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2311340.0A GB202311340D0 (en) 2023-07-24 2023-07-24 Cancer diagnosis and treatment

Publications (1)

Publication Number Publication Date
GB202311340D0 true GB202311340D0 (en) 2023-09-06

Family

ID=87852178

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2311340.0A Pending GB202311340D0 (en) 2023-07-24 2023-07-24 Cancer diagnosis and treatment

Country Status (1)

Country Link
GB (1) GB202311340D0 (en)

Similar Documents

Publication Publication Date Title
IL280707A (en) Diagnostic and therapeutic methods for the treatment of breast cancer
GB202018667D0 (en) Photodynamic therapy and diagnosis
IL307964A (en) Combination therapy for cancer treatment
IL308992A (en) Treatment of cancer in patients with soluble fr-alpha
EP4210704A4 (en) Pharmaceutical combination and tumor treatment
GB202311340D0 (en) Cancer diagnosis and treatment
GB202101728D0 (en) Compounds and their use treating cancer
GB202018015D0 (en) Composition and methods for the treatment of intestinal cancer
IL314984A (en) Oral pclx-001 in the treatment of human cancer
GB202308150D0 (en) Photodynamic therapy and diagnosis
GB202308146D0 (en) Photodynamic therapy and diagnosis
GB202308145D0 (en) Photodynamic therapy and diagnosis
IL313122A (en) Photodynamic therapy and diagnosis
IL313128A (en) Photodynamic therapy and diagnosis
GB202208161D0 (en) Photodynamic therapy and diagnosis
GB202208167D0 (en) Photodynamic therapy and diagnosis
GB202208170D0 (en) Photodynamic therapy and diagnosis
GB202208166D0 (en) Photodynamic therapy and diagnosis
GB202208165D0 (en) Photodynamic therapy and diagnosis
GB202208157D0 (en) Photodynamic therapy and diagnosis
GB202208164D0 (en) Photodynamic therapy and diagnosis
GB202303784D0 (en) Cancer treatment
GB202217305D0 (en) Cancer treatment
GB202018672D0 (en) Photodynamic therapy and diagnosis
GB202018673D0 (en) Photodynamic therapy and diagnosis